Clinical Trials on Macular in Mexico

Total 860 results

Asociación para Evitar la Ceguera en México

Unknown

Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Cystoid Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Bevacizumab and Retinal Vascular Occlusions

Vascular Occlusion | Edema Macular

Mexico
Instituto Nacional de Rehabilitacion

Not yet recruiting

BCI-FES for Upper Limb Rehabilitation in Chronic Stroke (BCI-FES)

Stroke | Upper Extremity Paresis | Neuronal Plasticity

Mexico
CMN "20 de Noviembre"

Completed

Distal Transradial Access for Coronary Angiography and Percutaneous Coronary Intervention.

Coronary Artery Disease

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment

Proliferative Diabetic Retinopathy | Non Proliferative Diabetic Retinopathy

Mexico
Instituto Mexicano del Seguro Social

Recruiting

Effect of Dapagliflozin on LV Remodeling Post AMI

Myocardial Infarction

Mexico
Laboratorios Sophia S.A de C.V.

Completed

Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. (PRO-155/IV)

Ocular Inflammation | Ocular Pain | Pterygium | Post-surgical Inflammation

Mexico
Hospital Juarez de Mexico

Unknown

Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
Instituto Nacional de Cardiologia Ignacio Chavez

Recruiting

Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk (ZEVS-HBR)

Coronary Artery Disease | Percutaneous Coronary Intervention | High Bleeding Risk

Mexico
Hospital Juarez de Mexico

Completed

Contrast Sensitivity and Diabetic Macular Edema

DIABETES MELLITUS | DIABETIC RETINOPATHY | MACULAR EDEMA

Mexico
Instituto Nacional de Cardiologia Ignacio Chavez

Terminated

Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty (DEBORA)

Coronary Artery Disease (CAD) | Percutaneous Coronary Intervention (PCI) | High Bleeding Risk

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO (MECROV)

Central Retinal Vein Occlusion | Macular Edema

Mexico
Grupo Cooperativo de Hemopatías Malignas

Withdrawn

Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma

Multiple Myeloma

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Effect of Topical Nepafenac in Macular Thickening Related to Pan-Retinal Photocoagulation (NEPAF)

Macular Edema | Macular Thickening

Mexico
Alcon Research
PPD

Terminated

1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT

Ocular Hypertension | Glaucoma

Mexico
Allegro Ophthalmics, LLC

Withdrawn

Safety Study of ALG- 1001 to Treat Diabetic Macular Edema

Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Completed

Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema

Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Unknown

POSTERIOR SUB-TENON'S Avastin

Diffuse Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study

Diffuse Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Completed

Unilateral Bevacizumab for Bilateral Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
Instituto de Oftalmología Fundación Conde de Valenciana

Recruiting

Large Macular Hole Closure Rate With Amniotic Membrane Graft With and Without Limitorrhexis

Macular Holes

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

Age Related Macular Degeneration

Mexico
AbbVie

Recruiting

Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy

Spasticity

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Intravitreal Bevacizumab for Age-Related Macular Degeneration

Age Related Macular Degeneration

Mexico
Laboratorios Sophia S.A de C.V.

Recruiting

Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema (PRO-169)

Diabetic Macular Edema

Colombia, Mexico
Bayer

Completed

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice (MAIA)

Retinal Disease

Mexico
Allergan

Completed

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Mexico, Colombia
Hospital Juarez de Mexico

Completed

Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema

Diabetic Retinopathy | Clinically Significant Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Efficacy of Retreatments With Intravitreal Bevacizumab

Age Related Macular Degeneration | Choroidal Neovascularization

Mexico
Allegro Ophthalmics, LLC

Completed

A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration

Macular Degeneration

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema

* Diffuse Diabetic Macular Edema

Mexico
Carmen Clapp
Universidad Autónoma de Querétaro; Instituto Mexicano de Oftalmologia (IMO); General... and other collaborators

Recruiting

Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
Hospital Juarez de Mexico

Completed

Diabetic Macular Edema Severity at Diagnosis

Diabetes Mellitus | Diabetic Retinopathy | Macular Edema

Mexico
Hospital Juarez de Mexico

Completed

Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema

Diabetic Retinopathy | Macular Edema

Mexico
Hospital Juarez de Mexico

Completed

Visual Function, Center Point Thickness and Macular Volume After Photocoagulation

Diabetic Retinopathy | Macular Edema

Mexico
Hospital Juarez de Mexico

Completed

Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy

Macular Edema | Proliferative Diabetic Retinopathy

Mexico
Laboratorios Sophia S.A de C.V.

Terminated

Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. (PRO-122)

Ocular Hypertension | Glaucoma, Open-Angle

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery

Epiretinal Membrane | Macular Hole

Mexico
Oraya Therapeutics, Inc.

Unknown

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Eye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Diseases | Wet Age-Related Macular Degeneration

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

Diabetic Macular Edema | Diabetes Mellitus Type 2

Mexico
Rush Eye Associates

Completed

ILM Peeling in PDR Patients Undergoing PPV for VH

Diabetic Retinopathy | Macular Edema

Mexico
Rush Eye Associates

Completed

PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME

Diabetic Retinopathy | Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Completed

Avastin for Post-Photocoagulation Macular Edema

Macular Edema

Mexico
Allergan S.A. DE C.V..

Completed

Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Glaucoma Primary Open Angle

Mexico
Coordinación de Investigación en Salud, Mexico
Instituto Nacional de Rehabilitacion

Completed

Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients

Muscular Dystrophy, Duchenne

Mexico
Laboratorios Sophia S.A de C.V.

Terminated

Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension (COMPLIANCE)

Primary Open Angle Glaucoma | Ocular Hypertension

Mexico
Progen Pharmaceuticals

Completed

Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD

Age Related Macular Degeneration

United States, Mexico, Russian Federation
Laboratorios Silanes S.A. de C.V.

Completed

Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension

Essential Arterial Hypertension

Mexico
Instituto Nacional de Cardiologia Ignacio Chavez
JOSE CARRASCO ARTEAGA HOSPITAL FROM Ecuadorian Institute of Social Security

Unknown

Correlation Between Access Blood Flow and Extracorporeal Blood Flow

Arteriovenous Fistula

Mexico

Clinical Trials on Macular in Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations